William Wood
Stock Analyst at B. Riley Securities
(3.30)
# 2,362
Out of 4,408 analysts
49
Total ratings
47.6%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by William Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Reiterated: Buy | $7 | $1.71 | +309.36% | 2 | Jun 2, 2026 | |
| EQ Equillium | Reiterated: Buy | $6 | $2.81 | +113.52% | 2 | Jun 2, 2026 | |
| IMUX Immunic | Maintained: Buy | $50 → $27 | $13.86 | +94.81% | 10 | May 22, 2026 | |
| AARD Aardvark Therapeutics | Maintained: Buy | $8 → $7 | $3.90 | +79.49% | 3 | May 15, 2026 | |
| ALT Altimmune | Maintained: Buy | $13 | $2.61 | +398.08% | 1 | Mar 6, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintained: Buy | $560 → $670 | $480.77 | +39.36% | 3 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiated Coverage: Buy | $5 | $1.52 | +228.95% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Maintained: Buy | $3 | $1.21 | +147.93% | 1 | Nov 21, 2025 | |
| VERU Veru Inc. | Reiterated: Buy | $50 | $3.00 | n/a | 7 | Feb 11, 2025 | |
| LFMD LifeMD | Maintained: Buy | $12 → $11 | $4.70 | n/a | 10 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $13.44 | n/a | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $4.00 | n/a | 4 | May 2, 2024 |
Palisade Bio
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $1.71
Upside: +309.36%
Equillium
Jun 2, 2026
Reiterated: Buy
Price Target: $6
Current: $2.81
Upside: +113.52%
Immunic
May 22, 2026
Maintained: Buy
Price Target: $50 → $27
Current: $13.86
Upside: +94.81%
Aardvark Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $3.90
Upside: +79.49%
Altimmune
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $2.61
Upside: +398.08%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintained: Buy
Price Target: $560 → $670
Current: $480.77
Upside: +39.36%
OKYO Pharma
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.52
Upside: +228.95%
Cognition Therapeutics
Nov 21, 2025
Maintained: Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Veru Inc.
Feb 11, 2025
Reiterated: Buy
Price Target: $50
Current: $3.00
Upside: n/a
LifeMD
Aug 8, 2024
Maintained: Buy
Price Target: $12 → $11
Current: $4.70
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $10
Current: $13.44
Upside: n/a
May 2, 2024
Maintained: Buy
Price Target: $4
Current: $4.00
Upside: n/a